Atlas Trials

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Clinical trial NCT06220123 · COMPLETED

Trial details

NCT number
NCT06220123
Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Start date
2024-02-16
Primary completion
2024-12-31
Enrollment
225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.